Ji Y. Hyun
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pharmabiotics, Phocaeicola dorei, ameliorates cholestatic liver fibrosis by alleviating macrophage efferocytosis of neutrophils.
Journal: Nature communications
Published: July 06, 2025
Impaired chaperone-mediated autophagy leads to abnormal SORT1 (sortilin 1) turnover and CES1-dependent triglyceride hydrolysis.
Journal: Autophagy
Published: November 29, 2024
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation.
Journal: Gut microbes
Published: February 01, 2024
Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease.
Journal: Scientific reports
Published: December 21, 2023
Systemic multiomics evaluation of the therapeutic effect of Bacteroides species on liver cirrhosis in male mice.
Journal: Microbiology spectrum
Published: October 11, 2023
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease.
Journal: Foods (Basel, Switzerland)
Published: July 20, 2022
The identification of metabolites from gut microbiota in NAFLD via network pharmacology.
Journal: Scientific reports
Published: July 05, 2022
The Link between Gut Microbiota and Hepatic Encephalopathy.
Journal: International journal of molecular sciences
Published: July 05, 2022
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
Journal: International journal of molecular sciences
Published: June 27, 2022
The Lactobacillus as a Probiotic: Focusing on Liver Diseases.
Journal: Microorganisms
Published: January 04, 2022
Diet-Regulating Microbiota and Host Immune System in Liver Disease.
Journal: International journal of molecular sciences
Published: May 28, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026